Vericel Announces Positive Top-Line Results From Phase 2b ixCELL-DCM Clinical Trial of Ixmyelocel-T in Patients With Heart Failure Due to Ischemic Dilated Cardiomyopathy Biotech Investing
Avita Medical Reports Positive Results from Randomized, Multicentre EU Study of ReGenerCell™ Biotech Investing
Genmab Announces European Regulatory Submission for Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL Biotech Investing
XBiotech Enrolls Final Patient in Phase I Portion of Clinical Study to Evaluate Antibody Treatment for Staphylococcus Aureus Biotech Investing
Vericel Enters Into $10 Million Credit Facility and $5 Million Term Loan Agreement With Silicon Valley Bank Biotech Investing
Matinas BioPharma Granted US Orphan Drug Designation for MAT2501 for Treatment of Non-Tuberculous Mycobacteria Infections Biotech Investing
DBV Technologies Announces Presentation from NIAID-sponsored CoFAR6 Phase II Trial Reaffirming Viaskin(R) Peanut Safety and Efficacy Biotech Investing
